1. Home
  2. SONM vs IMNN Comparison

SONM vs IMNN Comparison

Compare SONM & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonim Technologies Inc.

SONM

Sonim Technologies Inc.

HOLD

Current Price

$5.76

Market Cap

6.5M

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.75

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONM
IMNN
Founded
1999
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
12.9M
IPO Year
2019
1985

Fundamental Metrics

Financial Performance
Metric
SONM
IMNN
Price
$5.76
$3.75
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$182.61
AVG Volume (30 Days)
39.7K
33.6K
Earning Date
10-31-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,109,000.00
N/A
Revenue This Year
$127.68
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.17
N/A
52 Week Low
$4.75
$3.56
52 Week High
$114.84
$41.22

Technical Indicators

Market Signals
Indicator
SONM
IMNN
Relative Strength Index (RSI) 44.94 38.96
Support Level $4.93 $3.80
Resistance Level $6.86 $4.00
Average True Range (ATR) 0.50 0.18
MACD -0.09 0.00
Stochastic Oscillator 42.99 0.00

Price Performance

Historical Comparison
SONM
IMNN

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: